These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 31626342
21. Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma. Giovinazzo F, Turri G, Katz MH, Heaton N, Ahmed I. Br J Surg; 2016 Feb; 103(3):179-91. PubMed ID: 26663252 [Abstract] [Full Text] [Related]
22. Resection of the Portal-Superior Mesenteric Vein in Pancreatic Cancer: Pathological Assessment and Recurrence Patterns. Groen JV, van Manen L, van Roessel S, van Dam JL, Bonsing BA, Doukas M, van Eijck CHJ, Farina Sarasqueta A, Putter H, Vahrmeijer AL, Verheij J, Besselink MG, Groot Koerkamp B, Mieog JSD. Pancreas; 2021 Sep 01; 50(8):1218-1229. PubMed ID: 34714287 [Abstract] [Full Text] [Related]
23. Real-time and the in vivo detection of minute cancer invasion to the portal-superior mesenteric vein using contact endoscopy during a pancreatic cancer resection. Eguchi H, Ishikawa O, Ohigashi H, Takahashi H, Ohue M, Takenaka A, Tomita Y, Yano M. Am J Surg; 2009 Nov 01; 198(5):e66-71. PubMed ID: 19887180 [Abstract] [Full Text] [Related]
24. Surgical Outcomes of Pancreatectomy with Resection of the Portal Vein and/or Superior Mesenteric Vein and Jejunal Vein for Pancreatic Head Cancer: A Multicenter Study. Nagakawa Y, Jang JY, Kawai M, Kim SC, Inoue Y, Matsuyama R, Heo JS, Honda M, Sugiura T, Ohtsuka M, Mizuno S, Kwon W, Uemura K, Han HS, Sugimoto M, Okano K, Nakamura M, Wada K, Kumamoto Y, Osakae H, Tsuchida A, Yoon YS, Park JS, Yamaue H, Endo I. Ann Surg; 2023 May 01; 277(5):e1081-e1088. PubMed ID: 34913900 [Abstract] [Full Text] [Related]
25. Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration. Malleo G, Maggino L, Marchegiani G, Feriani G, Esposito A, Landoni L, Casetti L, Paiella S, Baggio E, Lipari G, Capelli P, Scarpa A, Bassi C, Salvia R. Pancreatology; 2017 May 01; 17(5):847-857. PubMed ID: 28843714 [Abstract] [Full Text] [Related]
30. Segmental portal/superior mesenteric vein resection and reconstruction with the iliac vein after pancreatoduodenectomy. Zhao X, Li LX, Fan H, Kou JT, Li XL, Lang R, He Q. J Int Med Res; 2016 Dec 01; 44(6):1339-1348. PubMed ID: 28322103 [Abstract] [Full Text] [Related]
32. Pancreatic adenocarcinoma: A simple CT score for predicting margin-positive resection in patients with resectable disease. Cassinotto C, Dohan A, Zogopoulos G, Chiche L, Laurent C, Sa-Cunha A, Cuggia A, Reinhold C, Gallix B. Eur J Radiol; 2017 Oct 01; 95():33-38. PubMed ID: 28987689 [Abstract] [Full Text] [Related]
33. [Diagnosis and treatment of pancreatic head cancer followed by mesenteric-portal vein invasion]. Kriger AG, Karmazanovsky GG, Smirnov AV, Kharazov AF, Gorin DS, Raevskaya MB, Galkin GV, Revishvili AS. Khirurgiia (Mosk); 2018 Oct 01; (12):21-29. PubMed ID: 30560841 [Abstract] [Full Text] [Related]
36. Indication for the use of an interposed graft during portal vein and/or superior mesenteric vein reconstruction in pancreatic resection based on perioperative outcomes. Hirono S, Kawai M, Tani M, Okada K, Miyazawa M, Shimizu A, Kitahata Y, Yamaue H. Langenbecks Arch Surg; 2014 Apr 01; 399(4):461-71. PubMed ID: 24663295 [Abstract] [Full Text] [Related]
37. Portal or superior mesenteric vein resection for pancreatic head adenocarcinoma: prognostic value of the length of venous resection. Kaneoka Y, Yamaguchi A, Isogai M. Surgery; 2009 Apr 01; 145(4):417-25. PubMed ID: 19303991 [Abstract] [Full Text] [Related]
38. Role of neoadjuvant treatment in resectable pancreatic cancer according to vessel invasion and increase of CA19-9 levels. Kim HS, Lee M, Han Y, Kang JS, Kang YH, Sohn HJ, Kwon W, Lee DH, Jang JY. J Hepatobiliary Pancreat Sci; 2023 Jul 01; 30(7):924-934. PubMed ID: 36652346 [Abstract] [Full Text] [Related]
39. Pancreatic adenocarcinoma with histologically proven portal vein infiltration: what is the outcome? Martin D, Petermann D, Fontanella S, Pu Y, Halkic N, Demartines N, Schäfer M. Eur J Gastroenterol Hepatol; 2018 Dec 01; 30(12):1507-1513. PubMed ID: 30222630 [Abstract] [Full Text] [Related]
40. Histopathologic tumor invasion of superior mesenteric vein/ portal vein is a poor prognostic indicator in patients with pancreatic ductal adenocarcinoma: results from a systematic review and meta-analysis. Song A, Liu F, Wu L, Si X, Zhou Y. Oncotarget; 2017 May 16; 8(20):32600-32607. PubMed ID: 28427231 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]